Stock Track | BAYZED HEALTH Soars 5.17% Intraday on Strong Adjusted Profit and Cash Flow Growth

Stock Track04-01

BAYZED HEALTH's stock price surged 5.17% during intraday trading on Wednesday, following the release of its annual results for the fiscal year 2025.

The company reported a 5.8% year-on-year decline in revenue to RMB 1.12 billion. However, key profitability metrics showed significant improvement, with adjusted net profit climbing 43.2% to RMB 17.94 million and adjusted EBITDA growing 10.6% to RMB 144.36 million. The adjusted EBITDA margin also expanded to 12.9% from 11.4% a year earlier.

Investors appeared to focus on the company's strengthened financial position, highlighted by a 31.9% jump in net operating cash inflow to a record high of RMB 222.34 million. Cash and cash equivalents more than doubled to RMB 616.0 million, supported by IPO proceeds, while the gearing ratio improved substantially to 36.6% from 46.9%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134531415?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 10:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134531415","market":"nz","top_or_hot":-1,"title":"Stock Track | BAYZED HEALTH Soars 5.17% Intraday on Strong Adjusted Profit and Cash Flow Growth","media":"Stock Track","content":"<p>BAYZED HEALTH's stock price surged 5.17% during intraday trading on Wednesday, following the release of its annual results for the fiscal year 2025.</p>\n<p>The company reported a 5.8% year-on-year decline in revenue to RMB 1.12 billion. However, key profitability metrics showed significant improvement, with adjusted net profit climbing 43.2% to RMB 17.94 million and adjusted EBITDA growing 10.6% to RMB 144.36 million. The adjusted EBITDA margin also expanded to 12.9% from 11.4% a year earlier.</p>\n<p>Investors appeared to focus on the company's strengthened financial position, highlighted by a 31.9% jump in net operating cash inflow to a record high of RMB 222.34 million. Cash and cash equivalents more than doubled to RMB 616.0 million, supported by IPO proceeds, while the gearing ratio improved substantially to 36.6% from 46.9%.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BAYZED HEALTH Soars 5.17% Intraday on Strong Adjusted Profit and Cash Flow Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BAYZED HEALTH Soars 5.17% Intraday on Strong Adjusted Profit and Cash Flow Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-01 10:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAYZED HEALTH's stock price surged 5.17% during intraday trading on Wednesday, following the release of its annual results for the fiscal year 2025.</p>\n<p>The company reported a 5.8% year-on-year decline in revenue to RMB 1.12 billion. However, key profitability metrics showed significant improvement, with adjusted net profit climbing 43.2% to RMB 17.94 million and adjusted EBITDA growing 10.6% to RMB 144.36 million. The adjusted EBITDA margin also expanded to 12.9% from 11.4% a year earlier.</p>\n<p>Investors appeared to focus on the company's strengthened financial position, highlighted by a 31.9% jump in net operating cash inflow to a record high of RMB 222.34 million. Cash and cash equivalents more than doubled to RMB 616.0 million, supported by IPO proceeds, while the gearing ratio improved substantially to 36.6% from 46.9%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02609","symbol_name":"佰泽医疗","start_time":0,"source_url":"","article_id":"1134531415","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134531415","pubTimestamp":1775009149,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BAYZED HEALTH's stock price surged 5.17% during intraday trading on Wednesday, following the release of its annual results for the fiscal year 2025. The company reported a 5.8% year-on-year decline...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02609":"佰泽医疗"},"translate_title":"个股赛道|BAYZED HEALTH盘中大涨5.17%因调整后利润和现金流强劲增长","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02609":1},"content_text":"BAYZED HEALTH's stock price surged 5.17% during intraday trading on Wednesday, following the release of its annual results for the fiscal year 2025.\nThe company reported a 5.8% year-on-year decline in revenue to RMB 1.12 billion. However, key profitability metrics showed significant improvement, with adjusted net profit climbing 43.2% to RMB 17.94 million and adjusted EBITDA growing 10.6% to RMB 144.36 million. The adjusted EBITDA margin also expanded to 12.9% from 11.4% a year earlier.\nInvestors appeared to focus on the company's strengthened financial position, highlighted by a 31.9% jump in net operating cash inflow to a record high of RMB 222.34 million. Cash and cash equivalents more than doubled to RMB 616.0 million, supported by IPO proceeds, while the gearing ratio improved substantially to 36.6% from 46.9%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134531415","isCrawlerRequest":true}